Résumé Un nouveau coronavirus, le SARS-CoV-2 est responsable de la première pandémie du XXIe siècle. Après la région de Wuhan, Hubei en Chine, premier cluster de ce virus, les pays européens, dont la France, sont actuellement les pays avec le plus de nouveaux cas de patients contaminés. Cette épidémie bouleverse l’organisation du corps médical et paramédical, notamment la prise en charge des patients de cancérologie, infectés ou non par le virus, tant elle mobilise de moyens de santé et nécessite en urgence une modification des pratiques médicales. Abstract À new coronavirus, named SARS-CoV-2, is responsible of the first pandemic in the 21st century. The outbreak of 2019 novel coronavirus disease (COVID19) first occurred in Wuhan, Hubei in China. European countries, and France, are now the main cluster, with thousands of new cases of COVID-19 patients. This epidemic requires such health care resources and an urgent modification of our medical procedures that it is about to upset profoundly the entire medical organization. In particular, the epidemic changes totally the management of patients in oncology, be they infected or not. We report hereby the testimonies of residents in oncology regarding modifications in health and patient care and the different organizations that are implemented in France, in two clusters of the infection, to cope with the virus. Residents, who are given higher autonomy, are especially concerned with the short- and long-term consequences of the situation for their patients.